1. Home
  2. LKFN vs ODTX Comparison

LKFN vs ODTX Comparison

Compare LKFN & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

N/A

Current Price

$58.10

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$20.42

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LKFN
ODTX
Founded
1872
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2009
2025

Fundamental Metrics

Financial Performance
Metric
LKFN
ODTX
Price
$58.10
$20.42
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
★ $66.50
$35.75
AVG Volume (30 Days)
142.8K
★ 245.6K
Earning Date
10-26-2026
11-12-2026
Dividend Yield
★ 3.61%
N/A
EPS Growth
★ 10.47
N/A
EPS
★ 2.17
N/A
Revenue
★ $985,000.00
N/A
Revenue This Year
$6.34
N/A
Revenue Next Year
$4.97
N/A
P/E Ratio
$26.68
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$54.36
$15.10
52 Week High
$65.43
$29.05

Technical Indicators

Market Signals
Indicator
LKFN
ODTX
Relative Strength Index (RSI) 29.64 48.10
Support Level $56.56 $22.30
Resistance Level $62.23 $28.53
Average True Range (ATR) 1.07 1.99
MACD -0.24 -0.22
Stochastic Oscillator 0.19 50.43

Price Performance

Historical Comparison
LKFN
ODTX

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare. The company's revenue is derived from the business of banking.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: